REFERENCES
- USRDS. Available at: http://www.usrds.org/atlas.aspx. Accessed January 4, 2012.
- Rohr J, Kittner S, Feeser B, . Traditional risk factors and ischemic stroke in young adults: The Baltimore–Washington Cooperative Young Stroke Study. Arch Neurol. 1996;53:603–607.
- Sánchez-Perales C, Vázquez E, García-Cortés MJ, . Ischemic stroke in incident dialysis patients. Nephrol Dial Transplant. 2010;25:3343–3348.
- Power A, Chan K, Singh SK, Taube D, Duncan N. Appraising stroke risk in maintenance hemodialysis patients: A large single-center cohort study. Am J Kidney Dis. 2012;59:249–257.
- Xu J, Li G, Wang P, . Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest. 2005;115:1275–1280.
- Li G, Xu J, Wang P, . Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation. 2008;117:1277–1282.
- Stec A, Semczuk A, Furmaga J, Ksiazek A, Buraczynska M. Polymorphism of the renalase gene in end-stage renal disease patients affected by hypertension. Nephrol Dial Transplant. 2011. in press.
- Buraczynska M, Zukowski P, Buraczynska K, Mozul S, Ksiazek A. Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and stroke. Neuromol Med. 2011;13:321–327.
- Farzaneh-Far R, Desir GV, Na B, Schiller NB, Whooley MA. A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: Data from the heart and soul study. PLoS One. 2010;5:e13496.
- Malyszko J, Zbroch E, Malyszko JS, Koc-Zorawska E, Mysliwiec M. Renalase, a novel regulator of blood pressure, is predicted by kidney function in renal transplant recipients. Transplant Proc. 2011;43:3004–3007.
- Zbroch E, Malyszko J, Malyszko J, Koc-Zorawska E, Mysliwiec M. Renalase in peritoneal dialysis patients is not related to blood pressure, but to dialysis vintage. Perit Dial Int. 2012;32(3), doi:10.3747/pdi.2011.00118.
- Wu Y, Xu J, Velazquez H, . Renalase deficiency aggravates ischemic myocardial damage. Kidney Int. 2011;79:853–860.
- Schlaich M, Socratous F, Eikelis N, Chopra R, Lambert G, Hennebry S. Renalase plasma levels are associated with systolic blood pressure in patients with resistant hypertension. J Hypertens. 2010;28:e437.
- Masuo K, Lambert GW, Esler MD, Rakugi H, Ogihara T, Schlaich MP. The role of sympathetic nervous activity in renal injury and end-stage renal disease. Hypertens Res. 2010;33:521–528.
- Tripepi G, Mattace-Raso F, Rapisarda F, . Traditional and nontraditional risk factors as predictors of cerebrovascular events in patients with end stage renal disease. J Hypertens. 2010;28:2468–2474.
- Yano Y, Hoshide S, Etoh T, Tamaki N, Yokota N, Kario K. Synergistic effect of chronic kidney disease and high circulatory norepinephrine level on stroke risk in Japanese hypertensive patients. Atherosclerosis. 2011;219:273–279.
- Zoccali C, Mallamaci F, Parlongo S, . Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation. 2002;105:1354–1359.
- Mallamaci F, Tripepi G, Maas R, Malatino L, Böger R, Zoccali C. Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease. J Am Soc Nephrol. 2004;15:435–441.